Global In-Silico Drug Discovery Market Report 2022: Industry Outlook and Demand Forecast to 2030 Featuring In-silico Medicine, Evotec, Charles River Labs, WuXi AppTec, Ligand Pharma, Simulation Plus

Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Global In-Silico Drug Discovery Market Report: By Product, Workflow, Technology, End-user - Industry Outlook and Demand Forecast to 2030" report has been added to's offering.

In 2021, the global in-silico drug discovery market was worth $2,331.8 million, and it is expected to reach $5,682.3 million by 2030, at a 10.4% of CAGR from 2021 to 2030.

The technological advancements in computational biology, rising usage of cloud-based applications in drug discovery, and increasing focus on decreasing medication errors are the main factors propelling the market. In-silico drug design is being used for hit-to-lead selection and to speed up and simplify hit identification, as well as to enhance metabolism, absorption, excretion, toxicity profiles, and distribution.

Because of the coronavirus spread, a study was undertaken on many sorts of molecules to better understand the virus's shape and discover a treatment. Several attempts have been made at computational drug design by using primary SARS-CoV2 protease.

Docking was used after the high-throughput virtual screening of millions of natural compounds and molecule databases. As a result of the never-ending attempts to develop particular medications for COVID-19, the in-silico drug discovery market experienced a positive impact.

Medical and R&D spending in the U.S. is expected to exceed $250 billion by 2020. The market's growth can also be attributed to a developed network of manufacturers and service providers. Furthermore, the FDA's input has aided in a flexible regulatory route as well as the resolution of various questions concerning the co-development process.

There are a number of big companies in the in-silico drug discovery market, which makes it fragmented. To keep ahead of the competition, they have entered into partnerships and collaborations in recent years. The players include Charles River Laboratories, Ligand Pharmaceuticals Incorporated, WuXi AppTec, Simulation Plus, Schrodinger Inc., Aragen Life Sciences Pvt. Ltd., Selvita, Curia Global Inc., Insilico Medicine, and Evotec.

Key Findings of In-Silico Drug Discovery Market Report

  • The increasing usage of cloud-based technologies is driving the in-silico drug discovery sector. Cloud computing gives pharmaceutical researchers access to nearly infinite computer resources and allows them to scale up and down their computing environment.
  • In 2021, artificial intelligence had the biggest market share, of more than 40%. As the rate of data digitalization in the healthcare industry increases, AI is being utilized to handle challenges in gathering and evaluating information, to solve complex clinical problems.
  • SaaS is expected to develop at the highest CAGR in the in-silico drug discovery market, of roughly 11% during the projected period. This is mostly because these solutions aid users in data analysis, decision making, and data mining, by providing decentralization, real-world data management, and a variety of other features.
  • The rapid technological developments in the field of computational biology also fuel the worldwide in-silico drug discovery sector. In the creation of novel pharmaceutical compounds, computational techniques have proved effective. The data processing and analysis steps of sequencing have been simplified with the improvements in computational biology, thus resulting in faster turnaround times and improved accuracy.
  • Fosun Pharma partnered with In-silico Medicine in January 2022. To create a new therapeutic portfolio, In-silico's end-to-end AI-driven drug discovery platforms will be merged with Fosun Pharma's clinical development and commercial experience.
  • In-silico Medicine and the University of Zurich teamed up in March 2022 to leverage In-silico's dynamic AI technology to discover new cystinosis treatments

Companies Featured

  • In-silico Medicine
  • Evotec
  • Charles River Laboratories
  • WuXi AppTec
  • Ligand Pharmaceuticals Incorporated
  • Simulation Plus

Key Metrics

Report AttributeDetails
No. of Pages180
Forecast Period2021 - 2030
Estimated Market Value (USD) in 2021$2331.8 Million
Forecasted Market Value (USD) by 2030$5682.3 Million
Compound Annual Growth Rate10.4%
Regions CoveredGlobal

Key Topics Covered:

Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segment
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders

Chapter 2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Industry Outlook
4.1. Market Dynamics
4.1.1. Trends
4.1.2. Drivers
4.1.3. Restraints/challenges
4.1.4. Impact analysis of drivers/restraints
4.2. Impact of COVID-19
4.3. Porter's Five Forces Analysis

Chapter 5. Global Market
5.1. Overview
5.2. Market Revenue, by Product (2017-2030)
5.3. Market Revenue, by Technology (2017-2030)
5.4. Market Revenue, by Workflow (2017-2030)
5.5. Market Revenue, by End-user (2017-2030)
5.6. Market Revenue, by Region (2017-2030)

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global In-Silico Drug Discovery Market

Contact Data